IBSS BIOMED S.A. is a dynamically developing company also in terms of research and development activities.
IBSS BIOMED S.A. has extensive experience in carrying out research and development activities, mainly on the basis of its own technological base and highly qualified staff. Research and development projects carried out by the company, concerning new products or improving the existing ones, are executed by interdisciplinary teams in collaboration with other entities, i.e. research institutes, universities or clinical centres, as well as other companies, including specialised SMB’s and other pharmaceutical and biotechnology companies.
Our R&D activities aim at turning research ideas into innovative products – our strategy is based on the execution of a project from its concept to the finished product.
The R&D activity of IBSS BIOMED S.A. is focused on developing:
- Products based on strains of probiotic bacteria;
- Schedule and therapeutic vaccines.
Furthermore, in order to meet market demands and quality standards, IBSS BIOMED S.A. still improves its existing original products (probiotics, vaccines, allergens), introduces new technologies, research methods and improves the work and equipment of its laboratories. During the work of R&D project teams and clinical trials, the company cooperates with independent experts.
Clinical trials regarding products already available on the market and new ones meet the highest international standards. They are carried out on the basis of ethical principles resulting from the Declaration of Helsinki and in accordance with the principles of Good Clinical Practice (ICH GCP).
The GMP (Good Manufacturing Practice) System that is in place at the company guarantees that the products manufactured by IBSS BIOMED S.A. fully meet quality and safety standards.